Determinants of participation in HIV clinical trials: The importance of patients' trust in their provider

HIV Clinical Trials

Volumn 10, Issue 2, 2009, Pages 104-109

  Volkmann, Elizabeth ^a,b   Claiborne, Deon ^a   Currier, Judith S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Clinical trials; HIV; Participation

Indexed keywords

ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DOCTOR PATIENT RELATION; FEMALE; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MOTIVATION; OUTPATIENT; PATIENT EDUCATION; PATIENT PARTICIPATION; PRIORITY JOURNAL; QUESTIONNAIRE; SOCIAL ASPECT; TRUST; ANALYSIS OF VARIANCE; ATTITUDE TO HEALTH; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; RESEARCH SUBJECT; UNITED STATES;

ANALYSIS OF VARIANCE; CLINICAL TRIALS AS TOPIC; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HIV INFECTIONS; HUMANS; LOS ANGELES; PATIENT PARTICIPATION; PHYSICIAN-PATIENT RELATIONS; PROSPECTIVE STUDIES; QUESTIONNAIRES; RESEARCH SUBJECTS; TRUST;

EID: 68149154914     PISSN: 15284336     EISSN: None     Source Type: Journal    
DOI: 10.1310/hct1002-104     Document Type: Article

References (23)

1. Sung NS, Crowley WF, Genel M, et al. Central challenges facing the national clinical research enterprise. JAMA. 2003;289:1278-1287.
2. Gifford AL, Cunningham WE, Heslin KC, et al. Participation in research and access to experimental treatment by HIV infected patients. New Engl J Med. 2002;346:1373-1382.
3. Stone VE, Mauch MY, Steger KA. Provider attitudes regarding participation of women and persons of color in AIDS clinical trials. J Acquir Immune Defi c Syndr Hum Retrovirol. 1998;19:245-253.
4. Joseph RR. Viewpoints and concerns of a clinical trial participant. Cancer. 1994;74:2692-2693.
5. Stone VE, Mauch MY, Seger K, et al. Race, gender, drug use, and participation in AIDS clinical trials. Lessons from a municipal hospital cohort. J Gen Intern Med. 1997;12:150-157.
6. Ling J, Rees E, Hardy J. What infl uences participation in clinical trials in palliative care in a cancer centre? Eur J Cancer. 2000;36:621-626.
7. Fallowfield LJ, Jenkins V, Brennan C, et al. Attitudes of patients to randomized clinical trials of cancer therapy. Eur J Cancer. 1998;34:1554-1559.
8. Ellis PM, Butow PN. Focus group interviews examining attitudes to randomised trials among breast cancer patients and the general community. Aust N Z J Public Health. 1998;22:528-531.
9. Ellis PM, Dowsett SM, Butow PN, Tattersall MH. Attitudes to randomized clinical trials amongst outpatients attending a medical oncology clinic. Health Expect.1999;2:33-43.
10. Freedberg KA, Sullivan L, Georgakis A, et al. Improving participation in HIV clinical trials: impact of a brief intervention. HIV Clin Trials. 2001;2:205-212.
11. Llewellyn-Thomas HA, Thiel EC, Sem FW, Woermke DE. Presenting clinical trial information: a comparison of methods. Patient Educ Counseling. 1995;25:97-107.
12. Westreich L, Levine S, Ginsburg P, Wilets I. Patient knowledge about electroconvulsive therapy: effect of an informational video. Convulsive Ther. 1995;11:32-37.
13. Ives NJ, Troop M, Waters A, et al. Does an HIV clinical trial information booklet improve patient knowledge and understanding of HIV clinical trials? HIV Med. 2001;2:241-249.
14. Priddy FH, Cheng AC, Salazar LF, Frew PM. Racial and ethnic differences in knowledge and willingness to participate in HIV vaccine trials in an urban population in Southeastern US. Int J STD AIDS. 2006;17:99-102.
15. Degner LF, Kristjanson LJ, Bowman D, et al. Information needs and decisional preferences in women with breast cancer. JAMA. 1997;277:1485-1492.
16. Ellis PM, Butow PN, Tattersall MH, Dunn SM, Houssami N. Randomized clinical trials in oncology: understanding and attitudes predict willingness to participate. J Clin Oncol. 2001;19:3554-3561.
17. Schneider J, Kaplan SH, Greenfi eld S, Li W, Wilson IB. Better physician-patient relationships are associated with higher reported adherence to antiretroviral therapy in patients with HIV infection. J Gen Intern Med. 2004;19:1096-1103.
18. Garber M, Hanusa BH, Switzer GE, et al. HIV-infected African Americans are willing to participate in HIV treatment trials. J Gen Intern Med. 2007;22:17-42.
19. Wendler D, Kington R, Madans J, et al. Are racial and ethnic minorities less willing to participate in health research? PLoS Med. 2006;3:e19.
20. Madge S, Mocroft A, Wilson D, et al. Participation in clinical studies among patients infected with HIV-1 in a single treatment centre over 12 years. HIV Med. 2000;1:212-218.
21. Kiwanuka N, Robb M, Kigozi G, et al. Knowledge about vaccines and willingness to participate in preventative HIV vaccine trials. J Acquir Immune Defic Syndr. 2004;36:721-725.
22. Cassileth BR, Lusk EJ, Miller DS, Hurwitz S. Attitudes toward clinical trials among patients and the public. JAMA. 1982;248:968-970.
23. Halpern SD, Metzger DS, Berlin JA, Ubel PA. Who will enroll? Predicting participation in a phase II AIDS vaccine trial. J Acquir Immune Defic Syndr. 2001;27:281-288.